Evidence-based criteria for allergen immunotherapy

Italian Journal of Allergy and Clinical Immunology

Volumn 17, Issue 4, 2007, Pages 143-147

  Frati, Fraco ^a   Puccinelli, P ^a   Valle, C ^b   Lanfredini, M ^b   Marcucci, F ^c   Incorvaia, C ^d  

^a Medical and Scientific Department   (Italy)

^b SAN PAOLO HOSPITAL   (Italy)

^c UNIVERSITY OF PERUGIA   (Italy)

^d ISTITUTI CLINICI DI PERFEZIONAMENTO   (Italy)

Author keywords

Allergen immunotherapy; Efficacy; Evidence based medicine; Safety; Strength of recommendation

Indexed keywords

ADRENALIN; ALLERGEN; ANTIHISTAMINIC AGENT; CORTICOSTEROID; IMMUNOGLOBULIN E ANTIBODY; IMMUNOLOGIC AGENT; MONTELUKAST; PLACEBO;

ALLERGIC ASTHMA; ALLERGIC DISEASE; ALLERGIC RHINITIS; BRONCHUS HYPERREACTIVITY; CLINICAL TRIAL; COCHRANE LIBRARY; DRUG ADMINISTRATION ROUTE; DRUG SAFETY; ECONOMIC ASPECT; EVIDENCE BASED MEDICINE; HAY FEVER; HUMAN; IMMUNOTHERAPY; REVIEW; SYMPTOM; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 41549133634     PISSN: 11206373     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Noon L. Prophylactic inoculation against hay fever. Lancet 1911;1:1572-3.
2. Frankland A, Augustin R. Prophylaxis of summer hay fever and asthma: a controlled trial comparing crude grass pollen extract with the isolated main protein components. Lancet 1954;i:1055-8.
3. Bousquet J, Lockey R, Malling HJ. WHO Position Paper. Allergen immunotherapy: therapeutical vaccines for allergic diseases. Allergy 1998;53(Suppl 54).
4. Bousquet J, van Cauwenberge P. Allergic Rhinitis and its Impact on Asthma (ARIA). Position Paper endorsed by WHO. J Allergy Clin Immunol 2001;108(Suppl 5):147-334.
5. Committee on Safety in Medicine. CSM update: desensitizing vaccines. BMJ 1986;293:948.
6. Lockey RF, Benedict LM, Turkeltaub PC, Bukantz SC. Fatalities from immunotherapy and skin testing. J Allergy Clin Immunol 1987; 79:660-77.
7. Canonica GW, Passalacqua G. Noninjection routes for immunotherapy. J Allergy Clin Immunol 2003;111:437-48.
8. Gidaro G, Marcucci F, Sensi L, Incorvaia C, Frati F, Ciprandi G. The safety of sublingual-swallow immunotherapy: an analysis of published studies. Clin Exp Allergy 2005;35:565-71.
9. Shekelle PG, Woolf SH, Eccles M, Grimshaw J. Developing guidelines. BMJ 1999;318:593-6.
10. Abramson MJ, Puy RM, Weiner JM. Is allergen immunotherapy effective in asthma? A meta-analysis of randomized controlled trials. Am J Respir Crit Care Med 1995;151:969-74.
11. Abramson MJ, Puy RM, Weiner JM. Allergen immunotherapy for asthma. Cochrane Database Syst Rev 2003;4: CD001186.
12. Portnoy JM, Van Osdol T, Williams PB. Evidence-based strategies for treatment of allergic rhinitis. Curr Allergy Asthma Rep 2004; 4:439-46.
13. Calderon MA, Alves B, Jacobson M, Hurwitz B, Sheikh A. Durham S. Allergen injection immunotherapy for seasonal allergic rhinitis. Cochrane Database Syst Rev 2007;1: CD001936.
14. Scadding GK, Brostoff J. Low dose sublingual therapy in patients with allergic rhinitis due to house dust mite. Clin Allergy 1986; 16:483-91.
15. Tari MG, Mancino M, Monti G. Efficacy of sublingual immunotherapy in patients with rhinitis and asthma due to house dust mite. A double blind study. Allergol Immunopathol 1990;10:277-84.
16. Troise C, Voltolini S, Canessa A, Pecora S, Negrini AC. Sublingual immunotherapy in Parietaria pollen induced rhinitis: a double-blind study. J Invest Allergol Clin Immunol 1995;5:25-30.
17. Bousquet J, Scheinmann P, Guinnepain MT, PerrinFayolle M, Sauvaget J, Tonnel AB, et al. Sublingual swallow immunotherapy (SLIT) in patients with asthma due to house dust mites: a double blind placebo controlled study. Allergy 1999;54:249-60.
18. Wilson DR, Torres LI, Durham SR. Sublingual immunotherapy for allergic rhinitis. Cochrane Database Syst Rev 2003;2:CD002893.
19. Wilson DR, Torres-Lima M, Durham S. Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis. Allergy 2005;60:4-12.
20. Miceli Sopo S, Macchiaiolo M, Zorzi G, Tripodi S. Sublingual immunotherapy in asthma and rhinoconjunctivitis; systematic review of paediatric literature. Arch Dis Child 2004;89:620-4.
21. Olaguibel JM, Alvarez-Puebla MJ. Efficacy of sublingual allergen vaccination for respiratory allergy in children. Conclusion from one meta-analysis. J Invest Allergol Clin Immunol 2005;15:9-16.
22. Penagos M, Compalati E, Tarantini F, Baena-Cagnani R, Huerta J, Passalacqua G, et al. Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trials. Ann Allergy Asthma Immunol 2006;97:141-8.
23. Calamita Z, Saconato H, Pelà AB, Atallah AN. Efficacy of sublingual immunotherapy in asthma: systematic review of randomized clinical trials using the Cochrane Collaboration method. Allergy 2006;61:1162-72.
24. Antico A, Pagani M, Crema A. Anaphylaxis by latex sublingual immunotherapy. Allergy 2006;61:1236.
25. Dunsky EH, Goldstein MF, Dvorin DJ, Belecanech GA. Anaphylaxis to sublingual immunotherapy. Allergy 2006;61:1235.
26. Eifan AO, Keles S, Bahceciler NN, Barlan IB. Anaphylaxis to multiple pollen sublingual immunotherapy. Allergy 2007;62:567-8.
27. Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, et al. Grading quality of evidence and strength of recommendation. BMJ 2004;328:1490.
28. Schunemann HI, Jaeschke R, Cook DJ, Bria WF, El-Sohl A, Ernst A, et al. An official ATS Statement: grading the quality of evidence and strength of recommendation in ATS guidelines and recommendations. Am J Respir Crit Care Med 2006;174:605-14.
29. Schadlich PK, Brecht JG. Economic evaluation of specific immunotherapy vs. symptomatic treatment of allergic rhinitis in Germany. Pharmacoeconomics 2000;17:37-52.
30. Berto P, Bassi M, Incorvaia C, Frati F, Puccinelli P, Giaquinto C, et al. Cost effectiveness of sublingual immunotherapy in children with allergic rhinitis and asthma. Eur Ann Allergy Clin Immunol 2005;37:303-8.
31. Berto P, Passalacqua G, Crimi N, Frati F, Ortolani C, Senna G, et al. Economic evaluation of sublingual immunotherapy in adults with pollen induced respiratory allergy: the Sublingual Immunotherapy Pollen Allergy Italy (SPAI) study. Ann Allergy Asthma Immunol 2006;97:615-21.
32. Ariano R, Berto P, Tracci D, Incorvaia C, Frati F. Pharmacoeconomics of allergen immunotherapy compared with symptomatic drug treatment in patients with allergic rhinitis and asthma. Allergy Asthma Proc 2006;27:159-63.
33. Ortolani C, Agostinis F, Amoroso S, Ariano R, Barbato A, Bassi M, et al. Practice parameters for sublingual immunotherapy. Monaldi Arch Chest Dis 2006;65:44-6.